Stocks and Investing Stocks and Investing
Wed, October 5, 2016

Biren Amin Maintained (VRTX) at Strong Buy with Increased Target to $105 on, Oct 5th, 2016


Published on 2024-10-25 18:47:35 - WOPRAI, Biren Amin
  Print publication without navigation


Biren Amin of Jefferies, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $104 to $105 on, Oct 5th, 2016.

Biren has made no other calls on VRTX in the last 4 months.



There are 2 other peers that have a rating on VRTX. Out of the 2 peers that are also analyzing VRTX, 1 agrees with Biren's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016


This is the rating of the analyst that currently disagrees with Biren


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $139 on, Thursday, July 28th, 2016

Contributing Sources